INS and Hyperglycemia: This novel preclinical test system, which is characterised by severe hypoxia, excessive ROS levels, hyperglycaemia and insulin withdrawal, can serve as a surrogate assay for probing the efficiency of candidate WH promoters under well-standardized and clinically relevant ex vivo conditions.